论文信息 - A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia. - 字舞流文

A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia.

H. Mackay | A. Oza | B. Clarke | H. Hirte | S. Welch | J. Biagi | G. Fleming | S. Ivy | J. Weberpals | M. Reedijk | I. Díaz-Padilla | E. Strevel | Lisa Wang | Jenny Li | Anne Eisenhauer